Esteban Braggio
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Protein Degradation and Inhibitors 44
- Ubiquitin and proteasome pathways 16
- Glycosylation and Glycoproteins Research 13
- Hematology 73
- Multiple Myeloma Research and Treatments 67
- Co-authors
- Rafaël Fonseca (62 shared papers)A. Keith Stewart (30 shared papers)P. Leif Bergsagel (30 shared papers)Chang-Xin Shi (13 shared papers)Laura A. Bruins (27 shared papers)Jessica Schmidt (12 shared papers)Yuan Xiao Zhu (22 shared papers)Scott Van Wier (16 shared papers)
- Journals
- Blood (64 papers)Blood Cancer Journal (10 papers)Journal of Clinical Oncology (9 papers)Cancer Research (5 papers)Leukemia (4 papers)
- Partner nations
- United StatesBrazilGermany
In The Last Decade
Esteban Braggio
147 papers receiving 4.0k citations
Esteban Braggio's Hit Papers
Peers
Comparison fields: 5 of 103
- Hematology 2.2k
- Genetics 873
- Pathology and Forensic Medicine 881
- Oncology 1.2k
- Molecular Biology 2.6k
Countries citing papers authored by Esteban Braggio
This map shows the geographic impact of Esteban Braggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esteban Braggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esteban Braggio more than expected).
Fields of papers citing papers by Esteban Braggio
This network shows the impact of papers produced by Esteban Braggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esteban Braggio. The network helps show where Esteban Braggio may publish in the future.
Co-authors
The 25 scholars most cited alongside Esteban Braggio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide Hit paper breakdown → | 2011 | 461 |
| 2 | Clonal competition with alternating dominance in multiple myeloma Hit paper breakdown → | 2012 | 456 |
| 3 | 2012 | 286 | |
| 4 | 2016 | 177 | |
| 5 | 2014 | 170 | |
| 6 | 2015 | 150 | |
| 7 | 2013 | 122 | |
| 8 | 2017 | 112 | |
| 9 | 2007 | 87 | |
| 10 | 2013 | 85 | |
| 11 | 2009 | 83 | |
| 12 | 2011 | 81 | |
| 13 | 2019 | 70 | |
| 14 | 2012 | 67 | |
| 15 | 2021 | 65 | |
| 16 | 2014 | 56 | |
| 17 | 2017 | 53 | |
| 18 | 2013 | 48 | |
| 19 | 2013 | 48 | |
| 20 | 2012 | 47 |
About Esteban Braggio
Esteban Braggio is a scholar working on Molecular Biology, Hematology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 154 papers that have together received 4.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (67 papers), Chronic Lymphocytic Leukemia Research (59 papers), Protein Degradation and Inhibitors (44 papers), Lymphoma Diagnosis and Treatment (38 papers), Ubiquitin and proteasome pathways (16 papers), Immunodeficiency and Autoimmune Disorders (15 papers), Peptidase Inhibition and Analysis (13 papers) and Glycosylation and Glycoproteins Research (13 papers). The work is most often cited by research in Hematology (2.2k citations), Genetics (873 citations), Pathology and Forensic Medicine (881 citations), Oncology (1.2k citations) and Molecular Biology (2.6k citations). Esteban Braggio has collaborated with scholars based in United States, Brazil and Germany. Frequent co-authors include Rafaël Fonseca, A. Keith Stewart, P. Leif Bergsagel, Chang-Xin Shi, Laura A. Bruins, Jessica Schmidt, Yuan Xiao Zhu, Scott Van Wier, Jan B. Egan and Jonathan J. Keats. Their work appears in journals such as Blood, Blood Cancer Journal, Journal of Clinical Oncology, Cancer Research and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.